"Sie finden in unserer Praxis nicht nur die üblichen neurologischen Leistungen sondern haben die Auswahl individueller Gesundheitsleistungen, die Sie zusätzlich zu den von den Krankenkassen getragenen Leistungen auf Wunsch in Anspruch nehmen können. Ein weiteres Fachgebiet "Psychiatrie und Psychotherapie" ergänzt seit April 2015 unser Leistungsspektrum. Im Oktober 2016 wurde unsere Praxis durch die Deutsche Multiple Sklerose Gesellschaft (DMSG) als MS-Zentrum ausgezeichnet. Wir bieten unseren MS-Patienten eine umfassende Betreuung sowie die Durchführung sämtlicher MS-Therapien im ambulanten Bereich."

During the past decade, Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen" are "Alzheimer Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen" in a lesser frequency.

Most popular intervention types in "Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BI 425809 dose 1" (2 trials), "BI 425809 dose 2" (2 trials), "BI 425809 dose 3" (2 trials) and "BI 425809 dose 4" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".